Cargando…

Performance evaluation of the UMIC(®) Cefiderocol to determine MIC in Gram-negative bacteria

BACKGROUND: Cefiderocol is a catechol-substituted cephalosporin with potent in vitro activity against carbapenem-resistant (CR) Gram-negative bacteria (GNB). Cefiderocol susceptibility testing is complex because iron concentrations need to be taken into consideration. Here, we assessed the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dortet, Laurent, Niccolai, Claudia, Pfennigwerth, Niels, Frisch, Stefanie, Gonzalez, Camille, Antonelli, Alberto, Giani, Tommaso, Hoenings, Robert, Gatermann, Soeren, Rossolini, Gian Maria, Naas, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320108/ https://www.ncbi.nlm.nih.gov/pubmed/37209112 http://dx.doi.org/10.1093/jac/dkad149

Ejemplares similares

Comparative evaluation of the UMIC Colistine kit to assess MIC of colistin of gram-negative rods
por: Bardet, Lucie, et al.
Publicado: (2019)

In Vitro Activity of Cefiderocol against Clinical Gram-Negative Isolates Originating from Germany in 2016/17
por: Wohlfarth, Esther, et al.
Publicado: (2023)

In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium
por: Oueslati, Saoussen, et al.
Publicado: (2022)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
por: Kaye, Keith S., et al.
Publicado: (2023)

Nosocomial outbreak by NDM-1-producing Klebsiella pneumoniae highly resistant to cefiderocol, Florence, Italy, August 2021 to June 2022
por: Coppi, Marco, et al.
Publicado: (2022)

Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience
por: Piccica, Matteo, et al.
Publicado: (2023)

UMIc: A Preprocessing Method for UMI Deduplication and Reads Correction
por: Tsagiopoulou, Maria, et al.
Publicado: (2021)

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

Evaluation of the Revogene Carba C Assay for Detection and Differentiation of Carbapenemase-Producing Gram-Negative Bacteria
por: Girlich, Delphine, et al.
Publicado: (2020)

Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France
por: Jousset, Agnès B., et al.
Publicado: (2023)

In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France
por: Naas, Thierry, et al.
Publicado: (2021)

Erratum to: In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France
por: Naas, Thierry, et al.
Publicado: (2021)

1455. Potential Mechanisms of Cefiderocol MIC Increase in Enterobacterales in In Vitro Resistance Acquisition Studies
por: Yamano, Yoshinori, et al.
Publicado: (2020)

In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates
por: Rima, Mariam, et al.
Publicado: (2023)

723. Synergistic Effect of Cefiderocol Combined With Other Antibiotics Against Cefiderocol High MIC Isolates From the Multi-National SIDERO-WT Studies
por: Yamano, Yoshinori, et al.
Publicado: (2019)

696. Mechanism of Cefiderocol high MIC mutants obtained in non-clinical FoR studies
por: Ito, Akinobu, et al.
Publicado: (2018)

Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
por: Syed, Yahiya Y.
Publicado: (2021)

P35 Heteroresistance to cefiderocol in clinical Gram-negative isolates
por: Watson, Celeste, et al.
Publicado: (2023)

Increased zinc levels facilitate phenotypic detection of ceftazidime-avibactam resistance in metallo-β-lactamase-producing Gram-negative bacteria
por: Simon, Michaela, et al.
Publicado: (2022)

Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence
por: Viale, Pierluigi, et al.
Publicado: (2023)

Awareness of antibiotic resistance: a tool for measurement among human and animal health care professionals in LMICs and UMICs
por: Pinto Jimenez, Chris, et al.
Publicado: (2023)

Evaluation of the EasyScreen™ ESBL/CPO Detection Kit for the Detection of ß-Lactam Resistance Genes
por: Gonzalez, Camille, et al.
Publicado: (2022)

Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
por: Syed, Yahiya Y.
Publicado: (2021)

Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens
por: Pybus, Christine A., et al.
Publicado: (2021)

Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing
por: Gaibani, Paolo, et al.
Publicado: (2022)

Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
por: Wu, Janet Y., et al.
Publicado: (2020)

719. Cefiderocol Retains Anti-Biofilm Activity in MDR Gram-Negative Pathogens
por: Pybus, Christine A, et al.
Publicado: (2019)

Susceptibility of cefiderocol and other antibiotics against carbapenem-resistant, Gram-negative bacteria
por: Wang, Yifan, et al.
Publicado: (2022)

Cefiderocol, a new antibiotic against multidrug-resistant Gram-negative bacteria
por: Silva, José Tiago, et al.
Publicado: (2021)

Case series of cefiderocol for salvage therapy in carbapenem-resistant Gram-negative infections
por: Gavaghan, Victoria, et al.
Publicado: (2022)

2132. Multicenter Evaluation of Eravacycline MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels
por: Traczewski, Maria M, et al.
Publicado: (2019)

Good Correlation of Cefiderocol Between In Vivo Efficacy Murine Thigh/Lung Infection Models and MIC Determined in Iron-Depleted Conditions
por: Yamano, Yoshinori, et al.
Publicado: (2017)

Structural and Functional Aspects of Class A Carbapenemases
por: Naas, Thierry, et al.
Publicado: (2016)

Cefiderocol
por: Soriano, María Cruz, et al.
Publicado: (2022)

2439. Outcomes of Minocycline Use on Gram-Negative Infections and Implications of MIC
por: Cheng, Jennifer, et al.
Publicado: (2018)

LiF Reduces MICs of Antibiotics against Clinical Isolates of Gram-Positive and Gram-Negative Bacteria
por: Syed, H. C., et al.
Publicado: (2012)

Evaluation of the Liquid Colony™ Produced by the FAST System for Shortening the Time of Bacterial Identification and Phenotypic Antimicrobial Susceptibility Testing and Detection of Resistance Mechanisms from Positive Blood Cultures
por: Bonaiuto, Chiara, et al.
Publicado: (2023)

Reproducibility of Ceftolozane/Tazobactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram-negative MIC Panels
por: Harrington, Amanda, et al.
Publicado: (2017)

Reproducibility of Ceftazidime/Avibactam MIC Results for Enterobacteriaceae and Pseudomonas aeruginosa Using MicroScan Dried Gram Negative MIC Panels
por: Humphries, Romney, et al.
Publicado: (2017)

2131. Multicenter Evaluation of Meropenem/Vaborbactam MIC Results for Enterobacteriaceae Using MicroScan Dried Gram-Negative MIC Panels
por: Garner, Omai, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jrnuag0uhoeo0vkbprtlvffsve